Wondering what is tirzepatide for? Learn its FDA-approved uses, how the GIP/GLP-1 injection works, dosing steps, side effects, and safety facts.
Tirzepatide is a prescription injectable medication used to treat type 2 diabetes and to help adults with obesity or excess weight lose weight and keep it off. It is also approved for moderate-to-severe obstructive sleep apnea in adults living with obesity. Tirzepatide works by activating two gut-hormone receptors at the same time, GIP and GLP-1, which reduces appetite, slows stomach emptying, and improves blood sugar control.
In the United States, tirzepatide is sold under two brand names: Mounjaro for type 2 diabetes and Zepbound for weight management and sleep apnea. Both are given as a once-weekly shot under the skin, and both require a prescription from a licensed healthcare provider.
What Tirzepatide Is FDA-Approved For
The FDA has approved tirzepatide for three specific uses, each supported by large clinical trials. It is not approved for general wellness or cosmetic weight loss, and it does not replace diet and physical activity.
| Brand name | Approved use | Who it is for |
|---|---|---|
| Mounjaro | Type 2 diabetes | Adults, used with diet and exercise to improve blood sugar |
| Zepbound | Chronic weight management | Adults with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related condition |
| Zepbound | Moderate-to-severe obstructive sleep apnea | Adults with obesity, used alongside a reduced-calorie diet and more physical activity |
Researchers are also studying tirzepatide in heart failure with preserved ejection fraction, fatty liver disease (MASH), chronic kidney disease, and prediabetes. Those remain investigational uses and are not part of the approved label.
How Tirzepatide Works in the Body
Tirzepatide is a dual agonist, which means it mimics two hormones your gut releases after you eat.
- GIP (glucose-dependent insulinotropic polypeptide): supports insulin release and appears to influence how the body stores and uses fat.
- GLP-1 (glucagon-like peptide-1): signals fullness to the brain, slows the stomach, and reduces the amount of sugar the liver releases.
The combined effect is a lower appetite, smaller portions, and steadier blood sugar. Because the drug also slows stomach emptying, many people feel full sooner and stay full longer.
How to Use Tirzepatide: Dosing Basics
Learning how to use tirzepatide is mostly about timing and consistency. The standard schedule is one subcutaneous injection per week, on the same day each week, at any time of day, with or without food. Common injection sites are the abdomen, thigh, or back of the upper arm, and the site should be rotated each week.
Treatment starts low and increases slowly to limit side effects. The table below shows the typical step-up schedule from the prescribing information.
| Step | Weekly dose | Typical duration |
|---|---|---|
| 1 | 2.5 mg | 4 weeks (starting dose, not intended for blood sugar control) |
| 2 | 5 mg | At least 4 weeks |
| 3 | 7.5 mg | At least 4 weeks |
| 4 | 10 mg | At least 4 weeks |
| 5 | 12.5 mg | At least 4 weeks |
| 6 | 15 mg | Maximum approved dose |
People who use compounded vials often ask how many mg is 50 units of tirzepatide. The answer depends entirely on the concentration of the vial, because units measure volume, not drug. At 10 mg/mL, 50 units equals 5 mg; at 20 mg/mL, the same 50 units equals 10 mg. Never estimate a dose by guesswork, and confirm the concentration with your prescriber or pharmacist.
Tirzepatide vs. Other GLP-1 Medications
Tirzepatide is frequently compared with semaglutide (Ozempic, Wegovy, Rybelsus) and liraglutide (Victoza, Saxenda). All three lower appetite and blood sugar, but they do not work the same way.
| Medication | Receptors activated | Common brands | Dosing frequency |
|---|---|---|---|
| Tirzepatide | GIP and GLP-1 | Mounjaro, Zepbound | Once-weekly injection |
| Semaglutide | GLP-1 | Ozempic, Wegovy, Rybelsus | Once weekly injection or daily oral tablet |
| Liraglutide | GLP-1 | Victoza, Saxenda | Once-daily injection |
Head-to-head trials have found that tirzepatide produces greater average weight loss and blood sugar reduction than semaglutide at the doses studied. Individual results vary, and the best option depends on your health history, insurance coverage, and tolerance.
Side Effects and Safety
Most side effects are digestive and often fade as the body adjusts. Common reactions include nausea, vomiting, diarrhea, constipation, stomach pain, and fatigue.
Less common but serious risks include pancreatitis, gallbladder disease, bowel obstruction, kidney injury from dehydration, and severe low blood sugar when tirzepatide is combined with insulin or sulfonylureas. Tirzepatide also carries a boxed warning about thyroid C-cell tumors and should not be used by anyone with a personal or family history of medullary thyroid cancer or MEN2 syndrome.
Tirzepatide is not approved for use during pregnancy, and it is not recommended for anyone with a prior severe allergic reaction to the drug. Tell your healthcare provider about all medications and conditions before starting treatment.
Compounded Tirzepatide and Related Peptide Questions
After the FDA resolved the tirzepatide shortage in late 2024, large-scale compounding of the drug was no longer permitted, and copies sold by online vendors are unapproved. Only FDA-approved products have been reviewed for purity, potency, and safety.
People researching injections often run into unrelated peptides, and the questions tend to be basic. For example, what is semax peptide used for and what is pt 141 good for refer to entirely different compounds studied for nerve and sexual-health research, not for blood sugar or weight. Anyone handling a powder peptide should also understand bac water what is it and how long is bac water good for in the fridge, because a contaminated diluent can ruin a vial and lead to infection. When in doubt, ask a pharmacist.
Tirzepatide can be an effective tool for type 2 diabetes and weight management, but it is a long-term prescription medicine with real side effects and real costs. Talk with a licensed healthcare professional about whether it fits your situation.
Frequently Asked Questions
What is tirzepatide used for in weight loss?
Tirzepatide is sold as Zepbound for chronic weight management in adults who have obesity (BMI 30 or higher) or overweight (BMI 27 or higher) with at least one weight-related condition such as high blood pressure or type 2 diabetes. It is used together with a reduced-calorie diet and increased physical activity. It is a prescription medicine, not an over-the-counter weight loss product.
Is tirzepatide the same as Ozempic?
No. Ozempic is semaglutide, which activates only the GLP-1 receptor. Tirzepatide activates both GIP and GLP-1, and it is marketed as Mounjaro for type 2 diabetes and Zepbound for weight management and sleep apnea. Both drugs are once-weekly injections, but they are different molecules with different dosing.
How long do you typically stay on tirzepatide?
Tirzepatide is generally intended for long-term use, because blood sugar and weight often return toward previous levels when the medication is stopped. Dose changes should be made only with your prescriber. Ask your healthcare provider how long treatment should continue based on your goals and health history.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.